CVE-2023-42435 — MEDIUM (5.5)

Vulnerability Description

The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.

CVSS Score

5.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

UNCHANGED

Confidentiality

LOW

Integrity

LOW

Availability

LOW

Affected Products

Vendor	Product	Versions
Dexma	Dexgate	20130114

Related Weaknesses (CWE)

CWE-352

References

https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource
https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party AdvisoryUS Government Resource

FAQ

What is CVE-2023-42435?

CVE-2023-42435 is a vulnerability with a CVSS score of 5.5 (MEDIUM). The affected product is vulnerable to a cross-site request forgery vulnerability, which may allow an attacker to perform actions with the permissions of a victim user.

How severe is CVE-2023-42435?

CVE-2023-42435 has been rated MEDIUM with a CVSS base score of 5.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-42435?

Check the references section above for vendor advisories and patch information. Affected products include: Dexma Dexgate.